必须声明标量变量 "@Script_ID"。  COVID-19与SARS临床特征对比分析-《赣南医学院学报》

[1]文志勇,刘伟华,冉云,等. COVID-19与SARS临床特征对比分析[J].赣南医学院学报,2020,40(02):1.
 WEN Zhi-yong,LIU Wei-hua,RANG Yun,et al. Comparative analysis of clinical characteristics between COVID-19 and SARS[J].,2020,40(02):1.
点击复制

 COVID-19与SARS临床特征对比分析()
分享到:

《赣南医学院学报》[ISSN:1001-5779/CN:36-1154/R]

卷:
40
期数:
2020年02期
页码:
1
栏目:
新型冠状病毒专题
出版日期:
2020-03-18

文章信息/Info

Title:
 Comparative analysis of clinical characteristics between COVID-19 and SARS
作者:
文志勇1刘伟华1冉云1谭松龄1黎艳1陈杰1李兴1龚敏1文剑波1刘志平2
 赣南医学院 1.附属萍乡市人民医院,江西  萍乡  337000;2.基础医学院,江西  赣州  341000
Author(s):
WEN Zhi-yong1 LIU Wei-hua1 RANG Yun1 TAN Song-ling1 LI Yan1 CHEN Jie1 LI Xing1 GONG Min1 WEN Jian-bo1 LIU Zhi-ping2
Gannan Medical University 1.The Affiliated Pingxiang People’s Hospital, Pingxiang, Jiangxi 337000; 2.School of Basic Medical Sciences, Ganzhou, Jiangxi 341000
关键词:
 COVID-19SARS-CoV-2SAR-CoV临床特征
Keywords:
 COVID-19 SRSA-CoV-2 SAR-CoV clnical features
分类号:
R563.1
文献标志码:
A
摘要:
2019年12月发生于中国武汉的新型冠状病毒肺炎(COVID-19),截止到2020年2月22日全国共累计确诊77 041例患者,远超过2003年急性呼吸综合征(SARS)在我国确诊的人数。此次引起流行的新型冠状病毒(SARS-CoV-2)和SARS-CoV、中东呼吸综合征病毒(MERS-CoV)同为β属新型冠状病毒。 此次暴发的SARS-CoV-2与SARS-CoV病毒感染的临床症状和传染性有所不同。SARS暴发距今已过去十余年,众多学者对SARS进行了很多研究。由于SARS-CoV与SARS-CoV-2有同源性,本文将这两种在中国引起暴发感染病毒造成的肺炎发病机制、临床特征进行比较。期望有助于控制疫情的发展。
Abstract:
In December 2019,pneumonia caused by a novel coronavirus occurred in Wuhan, China. Up to February 22, 2020, 77 041 cases have been confirmed in China, far more than the number of SARS cases in 2003. The novel coronavirus (SARS-CoV-2), SARS-CoV and Middle East respiratory syndrome virus (MERS-CoV), were the same as beta type new virus. The clinical symptoms and infectivity of SARS-CoV-2 and SARS-CoV infection are different. It has been about 17 years since the outbreak of SARS, many scholars have done a lot of researches on it. Because of the homology between SARS-CoV and SARS-CoV-2, the clinical features of SARS and SARS-CoV-2 viruses which mainly cause outbreak infection in China were compared. It is expected to help control the development of the epidemic.

参考文献/References:

[1]KOH D, SNG J. Lessons From the Past: Perspectives on Severe Acute Respiratory Syndrome[J]. Asia Pacific Journal of Public Health, 2010,22(3_suppl):132S-136S.
[2]COMAN V M, MUTH D, NIEMEYER D, et al. Hosts and Sources of Endemic Human Coronaviruses[J]. Advances in virus research, 2018,100:163.
[3]WHO. Novel Coronavirus (2019nCoV)[Z]. 2020.
[4]XU X, CHEN P, WANG J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci, 2020, 63(3):457-460. doi:10.1007/s11427-020-1637-5.
[5]LI M, MOORE MJ, VASILIEVA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J]. Nature, 2003(426):450-454.
[6]NETLAND J, PERLMAN S. Coronaviruses postSARS: update on replication and pathogenesis[J]. Nature Reviews Microbiology, 2009,7(6):439-450.
[7]杨秀红. 人ACE2转基因小鼠对SARS感性及SARS发病机制的实验研究[D].北京:中国协和医科大学,2017.
[8]IMAI Y, KUBA K, RAO S, et al. Angiotensinconverting enzyme 2 protects from severe acute lung failure[J]. Nature, 2005,436(7047):112-116.
[9]陈文莉, 陈小苹, 陈学福, 等. SARS患者T淋巴细胞亚群变化的初步研究[J].广东医学, 2003,24(S1):84-85.
[10]赖晃文, 赖日权, 田野, 等. 体液免疫在SARS发病机制中的作用[J].第三军医大学学报, 2004,26(14):1295-1297.
[11]边藏丽. SARS患者免疫系统的变化及发病机制研究进展[J].湖北省卫生职工医学院学报, 2004,17(1):8-10.
[12]WAN Y, SHANG J, GRAHAM R, et al. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS[J]. J Virol, 2020,JVI.00127-20. doi:10.1128/JVI.00127-20.
[13]LU R, ZHAO X, LI J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020,395(10224):565-574. doi:10.1016/S0140-6736(20):30251-8.
[14]陈嘉源,施劲松,丘栋安,等.2019新型冠状病毒基因组的生物信息学分析[J/OL].生物信息学:1-10[2020-02-24].http://kns.cnki.net/kcms/detail/23.1513.q.20200120.0839.002.html.
[15]HUANG C, WANG Y, LI X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020. DOI: 10.1016/S0140-6736(20)30183-5.
[16]刘映霞,杨扬,张聪,等.新型冠状病毒(2019-nCoV)感染患者肺损伤相关的临床及生化指标研究[J/OL].中国科学:生命科学:1-12[2020-02-24].http://kns.cnki.net/kcms/detail/11.5840.Q.20200212.0801.006.html.
[17]LIU Y, GAYLE AA, WILDERSMITH A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus[J]. J Travel Med, 2020,taaa021. doi:10.1093/jtm/taaa021.
[18]艾智华, 胡建林, 方勇飞. 严重急性呼吸综合征682例临床分析[J].第三军医大学学报, 2005(19):1967-1969.
[19]钟飞扬,张寒菲,王彬宸,等.新型冠状病毒肺炎的CT影像学表现[J/OL].武汉大学学报(医学版):1-5[2020-02-24].https://doi.org/10.14188/j.1671-8852.2020.0061.
[20]HUANG C, WANG Y, LI X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020. DOI: 10.1016/S0140-6736(20)30183-5.
[21]沈芳, 周志统, 蒋伟伦, 等. SARS患者淋巴细胞亚群和Th1/Th2细胞因子的检测与意义[J].现代免疫学, 2004(03):241-244.
[22]陆源, 宫恩聪, 张黔英, 等. 严重急性呼吸综合征冠状病毒在肺组织内各种类型细胞中的表达[J].北京大学学报(医学版), 2005(5):453-457.
[23]杨新艳, 要国华, 徐军, 等. 严重急性呼吸综合征冠状病毒S蛋白引起肺损伤的可能机制[J].中华结核和呼吸杂志, 2006(9):587-590.
[24]林琴, 王广发, 汤秀英, 等. SARS肺组织中CD34、VEGF、ICAM-1的表达及其意义[J].临床与实验病理学杂志, 2007(2):182-185.
[25]田春敏, 李培进, 程刚, 等. SARS急性肺损伤及其激素治疗的探讨[J].解放军预防医学杂志, 2007(5):387-389.
[26]赖蓓, 徐华, 黄慈波, 等. 以腹泻为首发症状的严重急性呼吸综合征患者的细胞免疫学特点[J].中国临床保健杂志, 2004(5):324-326.
[27]吴赤红, 徐小元, 陆海英, 等. 伴有腹泻的危重型SARS病人的临床特点分析与治疗[J].中国急救医学, 2004(1):38-40.
[28]赖日权, 冯晓冬, 王卓才, 等. SARS尸检组织的临床病理和超微结构观察, 2003[C].中华医学会系列杂志SARS研究论文集,2003.
[29]王烁, 潘世芬, 李春盛. 8例SARS合并上消化道出血患者的临床特点分析[J].中国危重病急救医学, 2004(10):595.
[30]陈明, 霍勇, 霍娜, 等. SARS患者的心脏表现[J].北京大学学报(医学版), 2003(5):556-557.
[31]陈杰, 张宏图, 谢永强, 等. 严重急性呼吸综合征的病理改变[J].中华病理学杂志, 2003(6):22-26.
[32]张卓彦, 赵爱斌, 王利花, 等. 22例传染性非典型肺炎临床分析[J].山西职工医学院学报, 2005(1):21-24.
[33]肖正伦, 黎毅敏, 陈荣昌, 等. 78例传染性非典型肺炎病例临床分析[J].中华结核和呼吸杂志, 2003(6):17-21.
[34]赵春惠, 郭雁宾, 吴昊, 等. 北京地区108例SARS患者临床特征、治疗效果及转归分析[J].中华医学杂志, 2003(11):5-9.
[35]霍娜, 陆海英, 徐小元, 等. 45例SARS病例早期临床特点及疗效的初步分析[J].北京大学学报(医学版), 2003,35(z1):19-22.
[36]李光辉, 贾楠. 120例传染性非典型肺炎临床分析[J].重庆医学, 2005(8):1169-1170.
[37]万华, 于岩岩, 斯崇文, 等. 53例SARS早期患者的临床分析[J].中华实验和临床病毒学杂志, 2004(1):74-76.
[38]WEI-JIE GUAN ZHENG YI, YU HU, et al. Clinical characteristics of 2019 novel coronavirus infection in China[J]. medRxiv preprint, 2020. doi:https://doi.org/10.1101/2020.02.06.20020974.
[39]CHEN N, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7.
[40]陆云飞,杨宗国,王梅,等.50例新型冠状病毒感染的肺炎患者中医临床特征分析[J/OL].上海中医药大学学报:1-5[2020-02-24].http://kns.cnki.net/kcms/detail/31.1788.R.20200208.1112.002.html.
[41]WANG D, HU B, HU C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China[J]. JAMA, 2020:10.1001/jama.2020.1585. doi:10.1001/jama.2020.1585.
[42]陈蕾, 刘辉国, 刘威, 等. 2019新型冠状病毒肺炎29例临床特征分析[J].中华结核和呼吸杂志, 2020(43):E5.
[43]LIU K, FANG YY, DENG Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province[J]. Chin Med J (Engl), 2020:10.1097/CM9.0000000000000744. doi:10.1097/CM9.0000000000000744.
[44]张明强, 王小辉, 安宇林, 等. 2019新型冠状病毒肺炎早期临床特征分析[J/OL].中华结核和呼吸杂志,2020,43(2020-02-15).[2020-02-24].http://rs.yiigle.com/yufabiao/1181338.htm. DOI: 10.3760/cma.j.issn.1001-0939.2020.0013.[网络预发表].
[45]WU JT, LEUNG K, LEUNG GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study[J]. Lancet, 2020,395(10225):689-697. doi:10.1016/S0140-6736(20)30260-9.
[46]HOLSHUE ML, DEBOLT C, LINDQUIST S, et al. First Case of 2019 Novel Coronavirus in the United States[J]. N Engl J Med, 2020,382(10):929-936. doi:10.1056/NEJMoa2001191.
[47]WANG M, CAO R, ZHANG L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro[J]. Cell Res, 2020, 30(3):269-271. doi:10.1038/s41422-020-0282-0.

相似文献/References:

[1]杨千绮,韩清波,莫建文,等.COVID-19流行期间医院非隔离病区疫情防控体系的构建与实施[J].赣南医学院学报,2020,40(02):1.
 YANG Qian-qi,HAN Qing-bo,MO Jian-wen,et al.Construction and implementation of the epidemic prevention and control system in non-isolation wards of hospitals during the epidemic period of COVID-19[J].,2020,40(02):1.
[2]黄贤平,谢树华,江丽玲,等.赣南地区儿童新型冠状病毒(SRAS-CoV-2)感染肺炎的临床特征及影像学特点分析[J].赣南医学院学报,2020,40(03):1.
 HUANG Xian-ping,XIE Shu-hua,JIANG Li-ling,et al.Analysis of clinical characteristics and imaging characteristics of COVID-2019 in children in Gannan region[J].,2020,40(02):1.
[3]文志勇,刘伟华,冉 云,等.COVID-19与SARS临床特征对比分析[J].赣南医学院学报,2020,40(02):109.[doi:10.3969/j.issn.1001-5779.2020.02.001]
 WEN Zhi-yong,LIU Wei-hua,RANG Yun,et al.Comparative analysis of clinical characteristics between COVID-19 and SARS[J].,2020,40(02):109.[doi:10.3969/j.issn.1001-5779.2020.02.001]
[4]杨千绮,韩清波,莫建文,等.COVID-19流行期间医院非隔离病区疫情防控体系的构建与实施[J].赣南医学院学报,2020,40(02):133.[doi:10.3969/j.issn.1001-5779.2020.02.006]
 YANG Qian-qi,HAN Qing-bo,MO Jian-wen,et al.Construction and implementation of the epidemic prevention and control system in non-isolation wards of hospitals during the epidemic period of COVID-19[J].,2020,40(02):133.[doi:10.3969/j.issn.1001-5779.2020.02.006]
[5]许志强,鲁陈,胡晓军,等. 新型冠状病毒SARS-CoV-2棘突蛋白免疫原性分析及其多肽疫苗设计研究[J].赣南医学院学报,2020,40(03):1.
 XU Zhi-qiang,LU Chen,HU Xiao-jun,et al. Epitope-based peptide vaccine design and immunogenicity analysis of the spike protein from SARS-CoV-2[J].,2020,40(02):1.

备注/Memo

备注/Memo:
基金项目:赣南医学院COVID-19应急项目(YJ202019)
作者简介:文志勇,男,硕士在读,住院医师,研究方向:消化道粘膜屏障功能。E-mail:729724369@qq.com
通信作者:文剑波,男,本科,教授/主任医师,研究方向:消化道疑难危重症的诊治及内镜下治疗。E-mail:wenjb@126.com
                    刘志平,男,博士,教授,研究方向:胃肠道炎症和癌症的机制研究。E-mail:Zhiping.Liu@gmu.edu.cn
(收稿日期:2020-02-24
更新日期/Last Update: 2020-03-18